Diabetic Renal-Retinal Syndrome Pathogenesis and Management Update 2002

Fresh insights into the pathogenic mechanisms by which hyperglycemia induces tissue and organ injurt are the basis for rapidly evolving promising therapies in diabetes. Especially promising as targets for intervention are products of oxidative stress, including kinins and growth factors. Improving r...

Full description

Bibliographic Details
Other Authors: Friedman, E.A. (Editor), L'Esperance Jr., Francis A. (Editor)
Format: eBook
Language:English
Published: Dordrecht Springer Netherlands 2002, 2002
Edition:1st ed. 2002
Subjects:
Online Access:
Collection: Springer Book Archives -2004 - Collection details see MPG.ReNa
LEADER 03035nmm a2200361 u 4500
001 EB000714828
003 EBX01000000000000000567910
005 00000000000000.0
007 cr|||||||||||||||||||||
008 140122 ||| eng
020 |a 9789401006149 
100 1 |a Friedman, E.A.  |e [editor] 
245 0 0 |a Diabetic Renal-Retinal Syndrome  |h Elektronische Ressource  |b Pathogenesis and Management Update 2002  |c edited by E.A. Friedman, Francis A. L'Esperance Jr 
250 |a 1st ed. 2002 
260 |a Dordrecht  |b Springer Netherlands  |c 2002, 2002 
300 |a XVIII, 246 p  |b online resource 
505 0 |a 1. Effect of Aminoguanidine on Induced-diabetic Rabbits and Diabetic Patients with ESRD -- 2. Impact of Nutrition in Uremic Diabetics -- 3. New Insights into the Molecular Mechanisms of Vascular Permeability in Diabetes -- 4. Apoptosis and Neurodegeneration in Diabetes: Lessons From the Retina -- 5. Diabetic Macular Edema -- 6. Diabetic Vitrectomy Update -- 7. Medical Approaches to Preventing Vision Loss from Diabetic Retinopathy -- 8. Ocular Findings at Onset of Uremia -- 9. Proliferative Diabetic Retinopathy: Current Treatment Strategies for Progression -- 10. Microalbuminuria in Perspectives -- 11. Which Comes First: Renal Injury or Microalbuminuria? -- 12. Prevention, Diagnosis and Management of Heart Disease in Patients with Renal Failure -- 13. Reducing Mortality for Diabetes Patients on Hemodialysis -- 14. Long-Term Perspective on Utility of Peritoneal Dialysis in Diabetes -- 15. Complications of Post-transplant Diabetes -- 16. Prevalent US Transplant Center Policies Towards Pancreas Transplantation for Patients with Type 2 Diabetes Mellitus -- 17. Pancreas Transplantation: Does It Have a Future? -- 18. Novel Applications for Recombinant Human Erythropoietin -- 19. Lessons Learned Since the Last Renal-Retinal Conference 
653 |a Nephrology 
653 |a Internal medicine 
653 |a Nephrology 
653 |a Diabetes 
653 |a Transplant Surgery 
653 |a Biochemistry, general 
653 |a Surgical transplantation 
653 |a Internal Medicine 
653 |a Biochemistry 
653 |a Diabetes 
700 1 |a L'Esperance Jr., Francis A.  |e [editor] 
041 0 7 |a eng  |2 ISO 639-2 
989 |b SBA  |a Springer Book Archives -2004 
856 4 0 |u https://doi.org/10.1007/978-94-010-0614-9?nosfx=y  |x Verlag  |3 Volltext 
082 0 |a 616.61 
520 |a Fresh insights into the pathogenic mechanisms by which hyperglycemia induces tissue and organ injurt are the basis for rapidly evolving promising therapies in diabetes. Especially promising as targets for intervention are products of oxidative stress, including kinins and growth factors. Improving results of renal replacement regimes now incorporating pancreatic islet transplants are able to delay and prevent end-organ damage in diabetic individuals. The evolving story of the taming of diabetes is of direct concern to nephrologists, endocrinologists, ophthalmologists, primary care physicians and medical students